NTS @ NPC
Neuromodulation: The Science at NPC
August 18-20, 2023
Meet the 2023 NTS @ NPC Chairs
Neuromodulation: The Science Conference joins the Napa Pain Conference August 18-20, 2023.
NTS @ NPC exists to advance research, dissemination of knowledge, and implementation of new findings within neuromodulation and is the foremost meeting addressing the emerging mechanisms of neuromodulation and how these advances shape technology and clinical implementation.
Neuromodulation: The Science (NTS) is established as the forum where leaders across academia, industry, and health-care converge to share and discuss emerging science underpinning and disrupting neuromodulation. Conference co-founder of NTS, Elliot Krames, MD established the journal Neuromodulation: Technology at the Neural Interface in 1998 as the preeminent journal to advance basic science research in the field of neuromodulation.
Dr. Eric Grigsby is CEO and Founder of Neurovations, a national leader in medical device and pharmaceutical innovation, clinical research, and a world-class education program focusing in pain and neuroscience.
Dr. Marom Bikson previously co-chaired Neuromodulation The Science (NTS) conference and will support the NTS content at Napa Pain. Dr. Bikson is founder of Neuromodec, a leading free online service created to support the development of neuromodulation through shared resources. The 2023 Napa Pain conference is partnered with Neuromodec.
Learn from Leaders
in Pain Medicine, Public Policy, Neurology, and more
Improve your care for persons with acute and chronic pain.
California Required CME on Pain Management and the Appropriate Treatment of the Terminally Ill
AB487 requires physicians licensed in California to complete a one-time CME activity for 12 hours of credits that addresses both pain management and the appropriate care and treatment of the terminally ill.
Portions of Napa Pain Conference Online contribute to AB487 and we’ve worked with the California Medical Board to support attendees under the Board’s new 2019 audit standards.
Minnesota Required CME on Opioid and Controlled Substance Prescribing
§214.12 subd. 6. AB487 requires licensees with the authority to prescribe controlled substances obtain at least two hours of continuing education credit on best practices in prescribing opioids and controlled substances, including nonpharmacological and implantable device alternatives for treatment of pain and ongoing pain management, as part of the continuing education requirements for licensure renewal. Licensees shall not be required to complete more than two credit hours of continuing education on best practices in prescribing opioids and controlled substances.
Portions of the Napa Pain Conference are designed to satisfy this statute for Minnesota licensees.
Why Choose Us?
Our team has over 14 years experience developing and managing medical education. Having contributed to more than 400 CME conferences, on 6 continents, from 50 attendees to over 20,000, you’re in good hands with Neurovations Education.
Neurovations Education is accredited to provide AMA PRA Category 1 CreditsTM.
Let us organize and maintain the your CME in compliance with ACCME, CMA/IMQ, FDA, OIG, AMA, California Assembly Bill 1195, PhRMA Code, Advamed, and CEJA rules, guidelines and regulations
Neurovations Education is a leader in medical education,. We began by establishing the oldest CME pain meeting in California (the Napa Pain Conference). Since then, Neurovations has emerged as an industry leader by placing quality education at the forefront of conference design.
Although results can’t be guaranteed, our Kaua’i Pain Conference and Napa Pain Conference have grown 30% year over year for three years.
Quality education, enthusiastic service and a well crafted program yield strong results.
Contact Education@Neurovations.com to take your conference to the next level.